A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth - Bertin Instruments

Scientific publications

A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth

M Kaliszczak1, S Trousil1, O Åberg1, M Perumal1, Q-D Nguyen1 and E O Aboagye*,1
Sources: 1Comprehensive Cancer Imaging Centre, Department of Surgery and Cancer Faculty of Medicine, Imperial College London, Hammersmith Hospital, Room 240, MRC Cyclotron Building, Du Cane Road, London W12 0NN, UK
British Journal of Cancer (2013), 1-9 | doi: 10.1038/bjc.2012.Environment

Sample name

Animal tissues (tumour xenograft mice)

Kits

CK14_2mL

ANY QUESTIONS? CONTACT AN EXPERT

Please fill in this form if you wish to contact our sales team or receive further information.

My Account
Forgot password ?

Add a question !

Add a question